Clinical Trial Update: A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD). [Phase 1]

View source ↗

Summary

A Phase 1 multiple ascending dose study evaluating safety, tolerability, and pharmacokinetics of RO4905417 in healthy volunteers and patients with Peripheral Ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• RO4905417

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Peripheral Arterial Disease (PAD) | Phase 1 | Status: COMPLETED